ConductScience.org, home

Paper6185902

Retinal ischemia and risk of neovascularization following central retinal vein obstruction.

Magargal LE and 2 others. Ophthalmology, 1982. Cited by 74 papers, by iCite.

Cite this record

ConductScience Library. Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Papers, record 6185902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6185902

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Retinal ischemia and risk of neovascularization following central retinal vein obstruction.
PubMed
Journal
Ophthalmology
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
3.69
iCite
Revised in PubMed
2019-07-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Magargal LEL E
2Donoso LAL A
3Sanborn GEG E

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
IschemiaMajor topic
Neovascularization, PathologicMajor topic
Retinal VeinMajor topic
Retinal VesselsMajor topic
Fluorescein Angiography
Glaucoma
Humans
Microcomputers
Retinal Diseases
Risk

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
38259837The progress of assessment methods and treatments of neovascular glaucoma secondary to central retinal vein occlusion.Front Med (Lausanne)2023https://conductscience.org/library/papers/38259837PubMed
33494354Multimodal Imaging of Microvascular Abnormalities in Retinal Vein Occlusion.J Clin Med2021https://conductscience.org/library/papers/33494354PubMed
32172031Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization.Biomaterials2020https://conductscience.org/library/papers/32172031PubMed
30972485A novel strategy for quantification of panoramic en face optical coherence tomography angiography scan field.Graefes Arch Clin Exp Ophthalmol2019https://conductscience.org/library/papers/30972485PubMed
29942024Relationship between Optical Intensity on Optical Coherence Tomography and Retinal Ischemia in Branch Retinal Vein Occlusion.Sci Rep2018https://conductscience.org/library/papers/29942024PubMed
28574924OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN RETINAL VEIN OCCLUSION: Correlations Between Macular Vascular Density, Visual Acuity, and Peripheral Nonperfusion Area on Fluorescein Angiography.Retina2018https://conductscience.org/library/papers/28574924PubMed
27490797Etiology and Features of Eyes with Rubeosis Iridis among Korean Patients: A Population-Based Single Center Study.PLoS One2016https://conductscience.org/library/papers/27490797PubMed
22960949A prospective, randomised, multicenter trial for surgical treatment of central retinal vein occlusion: results of the Radial Optic Neurotomy for Central Vein Occlusion (ROVO) study group.Graefes Arch Clin Exp Ophthalmol2013https://conductscience.org/library/papers/22960949PubMed
20379457Clinical progress in impending central retinal vein occlusion.Korean J Ophthalmol2010https://conductscience.org/library/papers/20379457PubMed
17406885Long-term effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series.Graefes Arch Clin Exp Ophthalmol2007https://conductscience.org/library/papers/17406885PubMed
12598443Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.Br J Ophthalmol2003https://conductscience.org/library/papers/12598443PubMed
9349161Central retinal vein occlusion: what's the story?Br J Ophthalmol1997https://conductscience.org/library/papers/9349161PubMed
8910031Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischaemia and reperfusion in the rat.Histochem J1996https://conductscience.org/library/papers/8910031PubMed
7612574Electroretinogram as indicator of prognosis of central retinal vein occlusion.Br J Ophthalmol1995https://conductscience.org/library/papers/7612574PubMed
4016064Chronic ocular ischaemia.Br J Ophthalmol1985https://conductscience.org/library/papers/4016064PubMed
3966997A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation.Br J Ophthalmol1985https://conductscience.org/library/papers/3966997PubMed
2361592Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase.Graefes Arch Clin Exp Ophthalmol1990https://conductscience.org/library/papers/2361592PubMed
1714760Neovascular response in ischaemic central retinal vein occlusion after panretinal photocoagulation.Br J Ophthalmol1991https://conductscience.org/library/papers/1714760PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6185902

GET https://conductscience.org/api/papers/v1/6185902/authors